Articles citing this paper
cfArticle2ecfc1291681887$funcTITLE@685e47d3
Edith Lau A , Alice Fabbri A and Barbara Mintzes A B
+ Author Affiliations
- Author Affiliations
A Charles Perkins Centre and School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, John Hopkins Drive, Camperdown, NSW 2006, Australia. Email: elau5098@uni.sydney.edu.au; alice.fabbri@sydney.edu.au
B Corresponding author. Email: Barbara.mintzes@sydney.edu.au
Australian Health Review 43(4) 474-480 https://doi.org/10.1071/AH17288
Submitted: 19 December 2017 Accepted: 9 May 2018 Published: 19 July 2018
8 articles found in Crossref database.
Exposing drug industry funding of UK patient organisations
Ozieranski Piotr,
Rickard Emily, Mulinari, Shai
BMJ. 2019 p.l1806
Advancing international comparison of pharmaceutical industry funding of patient advocacy: Focus on Denmark
Mulinari Shai,
Pashley Dylan, Ozieranski Piotr
Health Policy. 2022 126(12). p.1256
Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012–2016)
Ozieranski Piotr,
Csanádi Marcell,
Rickard Emily, Mulinari Shai
BMJ Open. 2020 10(9). p.e037351
Ethical Issues in Community and Patient Stakeholder–Engaged Health Research (2023)
Does Consumer Engagement in Health Technology Assessment Enhance or Undermine Equity?
Ghinea Narcyz,
Lipworth Wendy, Kerridge Ian
Journal of Bioethical Inquiry. 2020 17(1). p.87
‘Lines in the sand’: an Australian qualitative study of patient group practices to promote independence from pharmaceutical industry funders
Parker Lisa,
Grundy Quinn,
Fabbri Alice,
Mintzes Barbara, Bero Lisa
BMJ Open. 2021 11(2). p.e045140
National patient groups in Canada and their disclosure of relationships with pharmaceutical companies: a cross-sectional study
Lexchin Joel,
Batt Sharon,
Goldberg Devorah, Shnier Adrienne
BMJ Open. 2022 12(3). p.e055287
Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs
Mulinari Shai,
Vilhelmsson Andreas,
Rickard Emily,
Ozieranski Piotr, Lexchin Joel
PLOS ONE. 2020 15(6). p.e0235021
